The advance of adjuvant treatment for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by its highly aggressive behavior, early recurrence, and poor outcomes, when compared with other subtypes. Due to the absence of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao, Keda Yu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	China Anti-Cancer Association 2022-02-01
coleção:	Cancer Biology & Medicine
Assuntos:	triple-negative breast cancer adjuvant chemotherapy targeted therapy prognostic factors
Acesso em linha:	http://www.cancerbiomed.org/index.php/cocr/article/view/1902
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!